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Abstract
Background: Human immunodeficiency virus type 1 (HIV-1) uses cellular proteins and machinery to ensure 
transmission to uninfected cells. Although the host proteins involved in the transport of viral components toward the 
plasma membrane have been investigated, the dynamics of this process remain incompletely described. Previously we 
showed that the double-stranded (ds)RNA-binding protein, Staufen1 is found in the HIV-1 ribonucleoprotein (RNP) that 
contains the HIV-1 genomic RNA (vRNA), Gag and other host RNA-binding proteins in HIV-1-producing cells. Staufen1 
interacts with the nucleocapsid domain (NC) domain of Gag and regulates Gag multimerization on membranes 
thereby modulating HIV-1 assembly. The formation of the HIV-1 RNP is dynamic and likely central to the fate of the 
vRNA during the late phase of the HIV-1 replication cycle.
Results: Detailed molecular imaging of both the intracellular trafficking of virus components and of virus-host protein 
complexes is critical to enhance our understanding of factors that contribute to HIV-1 pathogenesis. In this work, we 
visualized the interactions between Gag and host proteins using bimolecular and trimolecular fluorescence 
complementation (BiFC and TriFC) analyses. These methods allow for the direct visualization of the localization of 
protein-protein and protein-protein-RNA interactions in live cells. We identified where the virus-host interactions 
between Gag and Staufen1 and Gag and IMP1 (also known as VICKZ1, IGF2BP1 and ZBP1) occur in cells. These virus-
host interactions were not only detected in the cytoplasm, but were also found at cholesterol-enriched GM1-
containing lipid raft plasma membrane domains. Importantly, Gag specifically recruited Staufen1 to the detergent 
insoluble membranes supporting a key function for this host factor during virus assembly. Notably, the TriFC 
experiments showed that Gag and Staufen1 actively recruited protein partners when tethered to mRNA.
Conclusions: The present work characterizes the interaction sites of key components of the HIV-1 RNP (Gag, Staufen1 
and IMP1), thereby bringing to light where HIV-1 recruits and co-opts RNA-binding proteins during virus assembly.
Background
HIV-1 replication is characterized by multiple virus-host
interactions that represent fundamental events enabling
viral propagation. While Gag is central to assembly,
numerous host proteins are also required for the genera-
tion of infectious HIV-1 particles [1]. The vRNA can both
be translated to produce Gag and Gag-Pol or packaged
into virions [2]. Gag selects the HIV-1 RNA genome
(vRNA) for packaging in the cytoplasm. These events
involve the regulated assembly of viral ribonucleoprotein
(RNP) complexes. This is a prerequisite for successful ret-
roviral vRNA trafficking from the nucleus into the cyto-
plasm, through the cytoplasm, and then into progeny
virions at sites of assembly [3,4]. Importantly, recent
studies show how vRNA transport mechanisms dictate to
what extent both the vRNA is translated and to what effi-
ciency Gag is assembled [5,6]. Studies also suggest that
the host factors that interact with viral Gag and RNA
might dictate intracellular trafficking events during viral
egress (reviewed in [7]).
Initially Gag is synthesized as a precursor molecule, but
is then cleaved to give rise to matrix (MA), capsid (CA),
nucleocapsid (NC), a late domain (p6) plus two spacer
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peptides SP1 and SP2 during and following virus bud-
ding. The protein domains of Gag play distinct roles in
the HIV-1 replication cycle (reviewed in [8]). During the
assembly process MA targets Gag to membranes via its
myristoylated highly basic N-terminus. Both the CA and
the NC domain function in Gag-Gag multimerization [9-
11]. Gag drives virion assembly and is sufficient for the
organization, budding and release of virus-like particles
(VLPs) from cells [12]. The association of Gag to mem-
branes is essential for efficient viral replication. In fact,
during viral egress, Gag rapidly associates to membranes
that target to assembly sites [13,14] with the concerted
activities of motor [15] and adaptor proteins [16-18].
Despite numerous studies, the contributions by cellular
factors to the transport of Gag towards viral assembly
platforms remain poorly understood. Recently, it was
demonstrated that Gag preferentially mediates viral
assembly at membrane lipid rafts. These are specific
detergent-resistant microdomains implicated in multiple
cellular processes (reviewed in [19]). HIV-1, like several
other pathogens, also relies on membrane lipid rafts to
complete its replication cycle (reviewed in [20]).
Previously, we demonstrated that Staufen1 interacts
with Gag via the NC domain and influences Gag multi-
merization [21]. Staufen1's presence in the HIV-1 RNP
that selectively contains the precursor Gag (pr55Gag) and
the vRNA and not any other HIV-1 RNA species [22,23]
and its eventual virion incorporation [24] promote the
idea that Staufen1 has a regulatory role in HIV-1 assem-
bly.
In the present study, we use BiFC analysis [25] to fur-
ther characterize and visualize the interactions between
Gag and Staufen1. Our results demonstrate that Staufen1
and Gag interact at both intracellular and plasma mem-
brane compartments. In addition, we show that Staufen1
is recruited by Gag to the plasma membrane at lipid raft
domains. TriFC analysis also showed that Staufen1 and
Gag were able to recruit each other while bound to
mRNA. Furthermore, when we depleted cells of Staufen1,
multimerized Gag molecules were inefficiently localized
to the plasma membrane, indicating that Staufen1 modu-
lates the localization of the assembling Gag. This work
provides new information on how HIV-1 co-opts cellular
factors to ensure proper viral assembly.
Results
Bimolecular fluorescence complementation (BiFC) to 
visualize Gag-Staufen1 interactions in live mammalian cells
Recently, the relationship between Staufen1 and precur-
sor Gag molecule (pr55Gag) was characterized. While
Staufen1 is found predominantly in the cytoplasm at the
endoplasmic reticulum [26]; Gag is localized in a punc-
tate, non-uniform pattern throughout the cytoplasm and
is enriched at the plasma membrane [13]. Here, we used
the BiFC assay because it enables live cell visualization of
protein-protein interactions. Moreover, it has proven to
provide a reliable read-out of protein-protein interaction
sites in several cell types and organisms [6,27-31]. As a
starting point for this part of our research, we studied the
interaction between Rev-dependent Gag proteins as
depicted in Figure 1A (top) [6]. Gag multimerized and
assembled with high efficiency as shown by strong green
fluorescence signals due to Gag-VenusC (VC) and
VenusN (VN) BiFC (Figure 1A, bottom panels). Gag-Gag
multimerization occurred at the plasma membrane, and
numerous Gag-Gag interaction events were also seen
within the cytoplasm.
We then characterized the interaction between Gag
and Staufen1. These proteins are known to interact in a
RNA-independent manner [22] and are in close proxim-
ity (≈10 nm) as determined by bioluminescence reso-
nance energy transfer experiments [21-23], thus we
expected to observe BiFC; but in addition, we wanted to
identify the interaction sites for this virus-host pair. We
detected small and large robust BiFC signals in the cyto-
plasm. Furthermore, a close examination of cells revealed
that the Staufen1 and Gag BiFC signals coincided with
the plasma membrane periphery (Figure 1B, top panels),
similar to what was found for Gag. This was observed in
over 90% of cells (n > 300) exhibiting BiFC.
We also performed BiFC to identify where Gag and
Insulin like growth factor II mRNA binding protein
(IMP1) interacted in cells. We chose IMP1 because it is a
component of the Staufen1 RNP [32,33] and because
IMP1 associates to Gag and is incorporated in HIV-1
[34,35]. The co-expression of Gag-VN and IMP1-VC gen-
erated intense BiFC signals predominantly in the cyto-
plasm (Figure 1B, bottom panels) with a detectable
amount at the plasma membrane in some cells (not
shown; see Figure 2C). IMP1-Gag exhibited a very spe-
cific and abundant interaction and shared some features
with the interaction site that we identified for Staufen1-
Gag including well defined cytoplasmic and plasma
membrane foci. The Gag-binding domain in IMP1 was
mapped to the four KH RNA-binding domains [35].
Therefore we performed BiFC analysis; and as expected,
the IMP1-KH(1-4)-Gag interaction was maintained (Fig-
ure 1C, top panels) whereas the expression of IMP1-
RRM(1-2), lacking the interaction domain, failed to com-
plement with Gag in this assay (Figure 1C, bottom pan-
els). A variety of other negative controls were performed.
For example, the co-expression of bacteriophage coat
protein MS2 fused to the VN moiety with either Gag-VC,
Staufen1-VC or IMP1-VC did not produce BiFC signals
in any cell, demonstrating the specificity of the method
(Additional file 1: Figure S1-A). Furthermore, we
expressed the BiFC Gag moieties along with pNL4.3 pro-
viral DNA at a 1:5 molar ratio in order to demonstrateMilev et al. Retrovirology 2010, 7:41
http://www.retrovirology.com/content/7/1/41
Page 3 of 19
that the resulting BiFC signals are specific and not due to
artifacts created by Gag-VC/VN overexpression or
changes in the kinetics of viral particle assembly, consis-
tent with an earlier report [36]. BiFC will only be positive
in cells expressing pNL4.3 in the presence of Rev. Impor-
tantly, this experimental set up, that also includes the
expression of the full complement of viral genes, leads to
identical BiFC signals (Additional file 1: Figure S1-B).
Finally, BiFC analyses were performed in Jurkat T cells,
and again, robust Gag-Gag and Gag-Staufen1 BiFC sig-
nals were evident at the periphery of T cells (Figure 1D).
Association of Gag and cellular factors at GM1-containing 
lipid rafts on the plasma membrane
Our earlier reports indicated that Staufen1 associates
with vRNA and Gag in both cells and virus [22,24]. Our
recent data suggest that this host protein modulates Gag
multimerization on membranes [21]. Gag preferentially
mediates viral assembly at specific sites on the plasma
Figure 1 Gag interactions with host proteins Staufen1 and IMP1 occur in the cytoplasm and at the plasma membrane of transfected HeLa 
and Jurkat T cells as determined by BiFC. (A) Top - schematic representation of BiFC method. Bottom - Rev-dependent Gag-VN and Gag-VC were 
co-transfected with pCMV-Rev in HeLa cells. At 24 hr post-transfection, cells were imaged by laser scanning confocal microscopy to detect BiFC. The 
white arrows indicate plasma membrane concentrated accumulations of Gag-Gag BiFC signals. (B) Gag-VN and Staufen1-VC (top panels) or Gag-VN 
and IMP1-VC (bottom panels) interactions identified by BiFC. BiFC signals for these interacting pairs were mainly detected in the cytoplasm (indicated 
by white arrows) and at or near the plasma membrane. (C) Interactions between Gag-VN with IMP1-KH(1-4)-VC (top) and with IMP1-RRM(1-2)-VC (bot-
tom) as determined by BiFC analysis. Evidence for interaction is demonstrated by a green fluorescence signal. (D) The interaction between Gag-VN 
and Gag-VC (top) or Gag-VN and Staufen1-VC (bottom) was determined by BiFC in Jurkat T cells. Magnified sections demonstrate details on the shapes 
of BiFC signals/complexes. The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
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Figure 2 Interactions between Gag and cellular proteins Staufen1 or IMP1 at GM1 containing lipid rafts on the plasma membrane as de-
termined by BiFC. (A) HeLa cells were co-transfected with pCMV-Rev and Rev-dependent Gag-VN and Gag-VC plasmids. At 24 hr post-transfection 
lipid raft staining in live cells was performed. Images were captured using laser scanning confocal microscopy to detect the co-localization patterns 
of oligomerizing Gag molecules and lipid raft microdomains (indicated by CT-B that binds the pentasaccharide chain of the raft marker protein, GM1). 
(B) Gag-VN/Staufen1-VC BiFC signals and CT-B staining in live cells. (C) Gag-VN/IMP1-VC BiFC signals and CT-B staining in live cells. (D) HeLa cells or 
(E) Jurkat T cells were co-transfected with pCMV-Rev and Rev-dependent Gag-VN and Gag-VC plasmids. At 24 hr post-transfection the cells were fixed 
in 4% paraformaldehyde (T cells were attached to poly-D-lysine coated coverslips before fixation), permeabilized in 0.2% Triton and stained for en-
dogenous Staufen1 and p17 to detect Gag (in Jurkat T cells only; (E), Gag is presented in blue). BiFC signals also identify Gag-Gag oligomers in fixed 
cells. Magnifications of cells on right show endogenous Staufen1 in Gag-Gag BiFC-negative (box 1) and positive (box 2) HeLa (D) or Jurkat T (E) cells. 
The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
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membrane called lipid raft microdomains [37,38] that are
composed of cholesterol and sphingolipids, and contain
several other components such as ganglioside GM1, gly-
cophosphatidylinositol-anchored (GPI-anchored) pro-
teins, tyrosine kinases of the Src family and others.
Because the Gag and Staufen1 interaction occurs also on
well defined plasma membrane structures (Figure 1B), we
next determined the nature of these interaction domains
using BiFC concomitant with live cell lipid raft staining.
We transfected cells with Gag-VN and Gag-, Staufen1- or
IMP1-VC BiFC constructs, and at 24 hr stained lipid rafts
using AlexaFluor 594-labeled cholera toxin subunit B
(CT-B) as described in Materials and Methods. As a ref-
erence condition for the association and multimerization
of Gag on the plasma membrane, we again used Gag-VN
and Gag-VC in BiFC (Figure 2A). We observed an almost
complete co-localization of CT-B label and oligomerizing
Gag, which is in accordance with previously published
work [39-41]. Furthermore, BiFC between Gag-VN and
Staufen1-VC followed by GM1 labeling revealed that a
substantial part of these interactions also occurred at
lipid rafts (Figure 2B). Likewise, a proportion of the Gag-
IMP1 BiFC signals coincided with lipid raft domains,
although as reported above, the plasma membrane local-
ization was not as marked (Figure 2C).
Staufen1's abundance at the plasma membrane was
puzzling since it is normally distributed in the cytoplasm
co-localizing with the endoplasmic reticulum [26,42].
Therefore, to determine if Staufen1 is recruited by Gag to
lipid raft domains, we co-transfected HeLa cells with the
BiFC plasmid pair Gag-VN and Gag-VC, and at 24 hr
post-transfection, we fixed and then stained the cells for
endogenous Staufen1 (Figure 2D). The BiFC signals
between Gag-VN/Gag-VC were observed at the plasma
membrane and were preserved following fixation. Nota-
bly, abundant staining for endogenous Staufen1 coin-
cided with the majority of the Gag BiFC signals in whole
cells (Figure 2D, left panel) and in the expanded region on
the right (Figure 2D, Gag-Gag positive cell) whereas in
Gag-Gag negative cells, Staufen1 was dispersed in the
cytoplasm. Thus, Staufen1 is recruited presumably by
Gag to plasma membrane lipid rafts. Finally, we per-
formed a similar analysis for endogenous Staufen1 in Jur-
kat T cells. Upon expression of Gag-VC and Gag-VN,
endogenous Staufen1 coincided with Gag BiFC signals at
cell-to-cell contact sites in Gag-expressing Jurkat T cells
(Figure 2E).
We also observed Staufen1-Gag BiFC signals at intrac-
ellular domains marked by CT-B. These sites appeared to
be vesicular in nature and were observed in ~75% of all
cells examined (in >200 cells in 6 experiments; Figure 2B,
white arrow). These sites of interaction with CT-B stain-
ing represent either rapidly internalized raft membrane
domains or sites of raft biogenesis/synthesis [43,44]. To
characterize them further, we performed time lapse
imaging of live cells. The structures were mostly immo-
bile, but several were dynamic showing characteristics of
membranes that were capable of fusion, fission, detach-
ment and subsequent trafficking towards the plasma
membrane (Additional file 2: Figure S2). This result sug-
gests that Gag passes through intracellular lipid raft
membrane domains on its way to the plasma membrane.
Biochemical fractionation of lipid rafts
We performed a detergent-free membrane flotation assay
to purify lipid rafts with the advantages that fewer insolu-
ble aggregates form, and the purifications are met with
less contamination from non-raft cellular membranes
([45]; Figure 3A). We either mock transfected HeLa cells
or co-transfected them with Gag-VN and Gag-VC plas-
mids to reproduce our BiFC conditions above. Alterna-
tively, cells were transfected with a Rev-dependent
GagΔNC/p6 construct [46] as a negative virus assembly
control. At 24 hr post-transfection cells were lysed,
washed and processed for fractionation. Eighteen frac-
tions from each gradient were probed for the raft marker
Caveolin-1 and for Staufen1, IMP1 and Tuberin (TSC2).
Gag was detected with either an anti-GFP (recognizing
VC of Gag-VC; Figure 3C) or with an anti-p24 (Figure
3D) antibody. Lipid rafts and associated proteins such as
Caveolin-1 accumulated principally in fractions #2 to #6
in all conditions (mock and in the presence of Gag or
truncated Gag proteins). The cytoplasmic protein TSC2
principally sedimented to fractions #12 to #18 (Figure 3B-
D, representing non-membrane fractions), but small
amounts were detected in association with rafts in the
upper fractions as reported [47]. In mock conditions, a
fraction of Staufen1 sedimented to the lipid rafts (≈6.5%
of total Staufen1; Figure 3B &3E). In the presence of Gag
however, a notable three-fold increase of Staufen1 (≈19%)
fractionated to lipid raft fractions (Figure 3C &3E) with
≈14% of total Gag sedimenting within these fractions. In
addition, a shift of IMP1 was observed within the gradi-
ent when Gag was expressed. Approximately 10% (vs ≈6%
in mock conditions) and ≈31% (vs ≈5% in mock condi-
tions) of IMP1 was found in lipid raft and intermediary
fractions (#7-#10), respectively. This was consistent with
our imaging data that detected a small proportion of
IMP1 in the lipid rafts in Gag-expressing cells (Figures 1
&2). Of interest is the observation that IMP1 overexpres-
sion disrupts the association of mature Gag products on
membranes [35]; therefore, the abundance of IMP1 on
lipid raft domains might be underrepresented. LAMP-3/
CD63 reactivity co-sedimented to these intermediary
fractions (M.P.M. & A.J.M., data not shown) and further
study of these membrane domains will be necessary. As a
control we expressed the assembly defective GagΔNC/p6
which can not bind to several host proteins like Staufen1,Milev et al. Retrovirology 2010, 7:41
http://www.retrovirology.com/content/7/1/41
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Figure 3 Staufen1 co-fractionates with Gag in lipid rafts. (A) A detergent-free method for the isolation and fractionation of lipid rafts. HeLa cells 
were mock transfected (B) or co-transfected with pCMV-Rev and Rev-dependent Gag-VN and Gag-VC (C) or Rev-dependent GagΔNC/p6 (D). At 24 
hr post-transfection, cells were harvested and fractionated on Optiprep gradients: lipid rafts fractionated in fractions #2-6 and non-membrane asso-
ciated proteins in the bottom fractions. Western blotting identified Caveolin-1 (Cav-1), Staufen1 (two isoforms: St-55, St-63), IMP1, TSC2, Gag-VC (in C) 
and p24 (to detect GagΔNC/p6 in (D)) in each fraction. (E) The relative quantities of Staufen1 in each fraction were measured using ImageJ software 
(NIH) (the sum of all fractions per condition = 1.0).Milev et al. Retrovirology 2010, 7:41
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IMP1 and HP68 (ABCE1), for example [22,35,46]. Nei-
ther GagΔNC/p6 nor Staufen1 sedimented to any great
extent to the lipid raft fractions (Figure 3D) indicating a
dependence on Gag for the enhanced recruitment of
Staufen1 to lipid rafts. These biochemical data reflect our
imaging data that showed a recruitment of Staufen1 to
lipid raft microdomains in the majority of Gag-trans-
fected cells (Figure 2B &2D).
Depletion of membrane cholesterol by hydroxy-propyl-β-
cyclodextrin (HβCD) reduces Gag-Gag and Gag-Staufen1 
membrane BiFC
Since cholesterol is essential for lipid raft structure and
function, its depletion should disrupt BiFC signals occur-
ring at these sites. Indeed, cholesterol depletion from the
rafts reduces the total amount of associated Gag and
more specifically the presence of higher-order Gag multi-
mers on the plasma membrane [38]. Thus, to confirm
that the plasma membrane domains where we find Gag-
Staufen1 BiFC are lipid rafts, we depleted cholesterol
from membranes using HβCD. At various time points
between 0 and 25 minutes, lipid rafts were detected by
CT-B staining; and the BiFC signals were imaged by laser
scanning confocal microscopy. Multimerized Gag dem-
onstrated strong association with GM1-containing lipid
microdomains before addition of HβCD (Figure 4A, t = 0
min). W e then perfused cells with HβCD and collected
i m a g e s  f r o m  l i v e  c e l l s  a t  t i m e  po i n t s  t h e r e a f t e r .  T i m e -
lapse imaging revealed a significant decrease in CT-B
staining at all time points after 15 minutes indicating that
HβCD was effective at disrupting lipid rafts. The BiFC
signals for Gag-Gag also dramatically decreased over
time (Figure 4A). The decreases in Gag-Gag and Gag-
Staufen1 BiFC signals were likely due to the disruption of
plasma membrane assembly domains thereby preventing
both the accumulation of Gag and the bimolecular inter-
actions. Because we took multiple laser scans of the same
cells, we attempted to rule out any effect photobleaching
might have in the BiFC and CT-B signals captured at the
later time points. We therefore transfected cells with a
Rev-dependent Gag construct and at 24 hr treated them
with HβCD over an extended period of time (0-45 min).
Cells were subsequently fixed, and immunofluorescence
was performed to obtain snapshots of the distributions of
Gag and of the raft marker protein, Caveolin-1 (Figure
4B). Indeed, both Caveolin-1 and Gag staining were
diminished over the course of this experiment. Therefore,
we can conclude that photobleaching is not significant in
these experiments, and also that the scaffold for interac-
tions between Gag and host proteins is disrupted by cho-
lesterol depletion. Finally, whereas the BiFC signals for
both the Staufen1-Gag and IMP1-Gag interactions were
observed at time 0 (data not shown but refer to Figures 2
and 3), these substantially decreased over time following
HβCD treatment indicating that intact lipid rafts contrib-
ute to these bimolecular interactions (Figure 4C).
Effects of modulating Staufen1 levels on the distribution of 
Gag-Gag BiFC complexes
To characterize the role of Staufen1 in the trafficking and
formation of Gag-Gag assembly complexes in live cells,
we depleted or overexpressed Staufen1 using siStaufen1
or a Staufen1-HA cDNA, respectively [22,24]. The deple-
tion of Staufen1 was efficient and reduced expression lev-
els to less than 1/6 while the over-expression increased
cellular Staufen1 levels approximately 6-fold (Figure 5A).
In cells transfected with a control siRNA (siNS) co-
expressing Gag-VN and Gag-VC, Gag BiFC was found at
the plasma membrane and in discrete cytoplasmic
domains as shown earlier (Figure 5B). However, in
Staufen1-depleted cells, in addition to the Gag-Gag BiFC
signals observed at the plasma membrane, strong signals
were observed at cytoplasmic juxtanuclear regions (Fig-
ure 5C). When Staufen1-HA was over-expressed, we
observed that the Gag-Gag BiFC punctae were abundant
and well defined, and we could not detect any marked
changes in plasma membrane association of Gag-Gag
BiFC compared to the control siNS condition (Figure
5D). Neither the depletion nor the over-expression of
Staufen1 caused any significant redistribution of ABCE1,
a host factor that interacts with NC domain of Gag and is
involved in assembly [46,48], in relationship to the local-
ization of Gag-Gag BiFC or gag RNA signals (Additional
file 3: Figure S3). Likewise, the depletion of the Staufen163
kDa isoform alone [49] or the depletion of UPF1 [32] did
not result in intracellular Gag BiFC signals (M.P.M., Lara
Ajamian and A.J.M., data not shown).
We noticed earlier that Gag-Gag BiFC occurred on
sometimes circular, membrane-like structures. Moreover,
Gag, Staufen1 and vRNA traffic on endosomal mem-
branes and in a manner that is dependent on endosomal
vesicle positioning [13,14]. Therefore to determine the
nature of the Gag structures, we co-expressed RFP fusion
marker proteins Rab5 (early endosomes), Rab7 (late
endosomes), Rab9 (Golgi/endoplasmic reticulum),
LAMP1 (late endosomes) and Caveolin-1 (lipid rafts/
caveosomes) in Staufen1-depleted cells. This analysis
revealed that the Gag-Gag BiFC signals were on mem-
branes that bore characteristics of endosomal mem-
branes/vesicles, consistent with recent work ([13,14];
Figure 6). Specifically, the Gag-Gag BiFC multimers that
coalesced intracellularly upon Staufen1 depletion coin-
cided to varying extents with late endosomal membrane
components LAMP-1-, Rab7- and on Rab9-containing
membranes. While Staufen1 depletion did not influence
the patterns of Rab7, Rab5, endoplasmic reticulum or
Golgi staining (M.P.M. and A.J.M., data not shown), we
nevertheless attempted to identify the origin of the GagMilev et al. Retrovirology 2010, 7:41
http://www.retrovirology.com/content/7/1/41
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Figure 4 Time-dependent depletion of cholesterol from lipid rafts leads to the disruption of Gag-Gag, Gag-Staufen1 or Gag-IMP1 BiFC. (A) 
HeLa cells were co-transfected with pCMV-Rev, Gag-VN and Gag-VC. At 24 hr post-transfection the cells were stained with the Vybrant Lipid Raft La-
beling Kit and treated with cholesterol disrupting drug HβCD (final concentration 30 mM). Pictures were taken at the indicated times post-HβCD treat-
ment. (B) HeLa cells were co-transfected with pCMV-Rev and the Rev-dependent Gag [46] and at 24 hr post-transfection were treated with HβCD for 
different periods of time (as indicated, for up to 45 min). The cells were then fixed, stained for Caveolin-1 and Gag and visualized by laser scanning 
confocal microscopy. (C) Hela cells were co-transfected with pCMV-Rev and either Gag-VN and Staufen1-VC or Gag-VN (top panels) and IMP1-VC (low-
er panels). At 24 hr post-transfection lipid rafts were identified in live cells using the Vybrant Lipid Raft Labeling and treated with HβCD for up to 25 
min. The BiFC signals were determined at t = 0 (not shown) and at the latest time point of t = 25 min. The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
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Figure 5 Staufen1 depletion decreases plasma membrane-associated Gag and results in intracellular clustering of Gag-Gag BiFC signals. 
HeLa cells were co-transfected with pCMV-Rev, Gag-VN and Gag-VC plasmids with control non-silencing siRNA (siNS), Staufen1 siRNA (siStaufen1) or 
Staufen1-HA. At 24 hr post-transfection cells were harvested for western blotting for Staufen1, Gag, Caveolin-1 and TSC2 (as loading controls) (A) or 
stained for lipid rafts in live cells. BiFC signals and lipid raft (CT-B) staining were captured by laser scanning confocal microscopy in cells transfected 
with siNS (B), siStaufen1 (C) or Staufen1-HA (D). Black and white images of lipid rafts (CT-B) and Gag-Gag BiFC signals and merged colour representa-
tions are shown. The insets are magnifications of boxed areas. The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
http://www.retrovirology.com/content/7/1/41
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Figure 6 Gag localizes near Rab7-, Rab9- and LAMP1-containing membranes at cytoplasmic and juxtanuclear sites in Staufen1-depleted 
cells. HeLa cells were transfected with pCMV-Rev, Gag-VN and Gag-VC with either siNS or siStaufen1 siRNAs and one of the following plasmids: (A) 
Rab5-RFP, (B) Rab7-RFP, (C) Rab9-RFP, (D) LAMP1-RFP or (E) Caveolin-1-RFP. At 24 hr post-transfection, the distributions of Gag-Gag BiFC and RFP fu-
sion proteins were visualized in live cells by laser scanning confocal microscopy. The insets show zoomed boxed regions of cells to demonstrate the 
levels of co-localization of Gag-Gag BiFC signals with either of membrane marker proteins. White arrows identify Gag-Gag BiFC aggregates. The size 
bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
http://www.retrovirology.com/content/7/1/41
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BiFC signals in Staufen1-depleted cells. To do this, we
overexpressed two trans-dominant negative (TDN) pro-
teins that efficiently block endocytosis at various steps as
described [13]. These include Eps15-TDN-GFP and
Rab7-TDN-GFP. These have been shown to block early
endocytic events as shown by a block to Transferrin
receptor recycling. Identical distributions of the Gag
(expressed here as Rev-dependent Gag only [46]) signals
were obtained when clathrin-dependent and clathrin-
independent (M.P.M. and A.J.M., data not shown) endo-
cytosis was blocked in Staufen1-depleted cells (Addi-
tional file 4: Figure S4 and data not shown). Therefore, we
propose that the localization of the BiFC signals obtained
in Staufen1-depleted cells was unlikely to be due to endo-
cytosed Gag-Gag multimers (see Discussion).
Trimolecular fluorescence complementation (TriFC) to 
visualize specific Gag- RNA interactions in living 
mammalian cells
Gag-Gag and Gag-Staufen1 interactions as visualized by
B i F C  w e r e  f o u n d  c o n s i s t e n t l y  i n  t h e  cyt o p l a s m  a n d  a t
plasma membrane lipid raft domains. Because both Gag
and Staufen1 bind mRNAs, we therefore explored how
the association to mRNA would influence the Gag-Gag
and Gag-Staufen1 associations. To do this, we employed
TriFC, a method that allows the detection of protein-
RNA or protein-protein-RNA interactions in live cells
[33]. To validate this assay we took advantage of the well
characterized Gag-vRNA association mediated by the psi
RNA packaging signal sequence. Thus, we generated con-
structs that expressed mRNAs containing either the com-
plete packaging signal psi  (pGL3MS2site-psi; including
SL2 and SL3 sequences), or delta psi domain in which 19
nucleotides are deleted from SL3 (pGL3MS2site-Delta-
psi; Table 1; [50]). The mRNA reporters, based on
pGL3MS2 site/basic [33], were also designed to contain
an MS2 binding site that provides an efficient tethering of
MS2-VN fusion protein. The KD of this interaction falls in
the nanomolar range [51], and it likely occurs rapidly and
is stable. As shown in Figure 7A in order for the success-
ful complementation of both VN and VC fragments the
simultaneous expression of three plasmids is required. In
the first case the VN is expressed as a fusion MS2-VN
protein and can tether to the RNA reporter in proximity
to the psi sequence (Figure 7A). hGag-VC will interact
with the psi domain of the reporter to allow for fluores-
cence complementation (Figure 7A); or when the psi is
mutated, fluorescence complementation will not occur
(Figure 7B). Using this assay, we found intense TriFC sig-
nals in the juxtanuclear region and cytoplasm (Figure
7C). In contrast, we did not detect TriFC when the
mRNA reporter harboring the mutated psi (delta psi) was
expressed (Figure 7D), and this was found in at least 5
experiments and having examined >400 viable cells. This
Table 1: List of plasmids used in this study.
Plasmid name Source or reference
pMS2-VenusFL [33]
pMS2-VN [33]
pMS2-Staufen1 This study
pMS2-hGag This study
pIMP1-VC [33]
pIMP1-KH(1-4)-VC [33]
pIMP1-RRM(1-2)-VC [33]
pStaufen1-VC This study
pStaufen1-HA [24]
phGag-VC This study
pMS2-Gag(C36S) This study
pGag-VN [6]
pGag-VC [6]
pCMV-Rev NIH
pSVGagRRE-R [70]
pGag- NC/p6(Tr361) [46]
pGL3MS2 site/basic [33]
pGL3-βActin zipcode [33]
pGL3MS2site-psi This study
pGL3MS2site-Delta-psi This study
pEps15-TDN-GFP [13]
pRab5-TDN-GFP [13]
mRFP-Rab5 Addgene plasmid 14437, [71]
dsRed-rab7 Addgene plasmid 12661, [72]
dsRed-rab9 WT Addgene plasmid 12677, [72]
Cav1-mRFP Addgene plasmid 14434, [73]
LAMP1-RFP Addgene plasmid 1817, [74]Milev et al. Retrovirology 2010, 7:41
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result was in accordance with our expectation because
packaging into virions of the virus-specific RNA harbor-
ing this deletion was less than 2% of that of the wild-type
virus [50]. These findings indicate that the association of
Gag with mRNA reporter molecules is sufficient to
sequester them into granules that bear hallmark appear-
ance of RNP containing proteins and mRNA [33]. The
experiments demonstrated the biological relevance and
specificity of the interactions between Gag and the HIV-1
vRNA psi packaging domain detected by TriFC. When
full-length Venus was expressed in the context of the
fusion MS2-Venus and co-expressed with the reporter
mRNA bearing MS2 binding domains, a uniformly dis-
tributed fluorescence signal was obtained throughout the
cell, in contrast to what we have obtained above (Addi-
t i o n a l  f i l e  5 :  F i g u r e  S 5 ) .  A d d i t i o n a l  n e g a t i v e  c o n t r o l s
included the expression of a psi  mRNA reporter
(pGL3MS2site-Delta-psi), the expression of Staufen1- or
IMP1-VC fusion proteins (Figure 7E &7F) or the exclu-
sion of the VN or VC expression vectors in the transfec-
tions (M.P.M. and A.J.M., data not shown). We also
expressed an mRNA reporter that contains the β-Actin
zipcode RNA sequence, and we did not detect fluores-
cence complementation (Figure 7G), whereas a strong
fluorescence signal was obtained using the cognate bind-
ing protein IMP1-VC (Figure 7H; [33]). Because Gag
expression is Rev-independent and may traffic aberrantly
in this set of experiments, we modified the TriFC assay
and employed a Rev-dependent Gag expressor. We co-
expressed the luciferase mRNA reporter harboring the
psi domain (or a mutated form as described above), MS2-
VN to tether to the MS2 RNA loops, Staufen1-VC, a Rev-
dependent Gag expressor [46] and pCMV-Rev as
d e p i ct ed  ( A d d i t i o n a l  f i l e  6 :  F i gu r e  S 6 - A ) .  I n  t h is  s e t u p
Gag must be brought in proximity to the RNA in order to
recruit Staufen1-VC to generate a TriFC signal. Indeed,
robust TriFC signals were obtained in cells. The removal
of MS2-VN, mutation of psi RNA and the expression of
Rev-dependent GagΔNC/p6 ([46]; Additional file 6: Fig-
ure S6-B) abrogated the TriFC signals in all cells exam-
ined demonstrating the specificity of the assay.
TriFC visualization of protein-protein recruitment and 
interactions on mRNA template
Using TriFC, we next evaluated whether Gag, while teth-
ered to the mRNA, could recruit Staufen1 and other host
proteins. MS2-Staufen1, MS2-hGag and MS2-Gag(C36S)
expression constructs were created for this purpose.
When mRNA reporters are co-expressed with MS2-VN
and MS2-fusion proteins, these molecules will tether to
the same MS2 RNA-binding site (MS2BS) on the mRNA.
This is a native property of the bacteriophage coat pro-
tein that binds the MS2BS hairpin as a dimer [52,53]. In
addition, in this system we expressed a second protein of
interest as a fusion with VC. When MS2-hGag was co-
tethered with MS2-VN to the mRNA reporter without
any additional protein binding domains [33], hGag-VC
was recruited to the mRNA as evidenced by bright TriFC
signals (Figure 8A). At the later time point (40 hr), the
punctae were larger, more abundant and were better
defined. Nevertheless, the signal intensity and abundance
of TriFC signals generally correlated with protein expres-
sion levels (Figure 8A). mRNA-tethered MS2-hGag
recruited both Staufen1-VC and IMP1-VC (Figure 8B
&8C). TriFC signals had apparent sizes ranging from 0.2
to 1.25 μm in diameter and were distributed in the cyto-
plasm of host cells, similar to what we found for hGag
proteins (see Discussion). Because NC is the interacting
domain for APOBEC3G [54], Staufen1 [22], and IMP1
[35], we tethered MS2-Gag(C36S) along with MS2-VN
and assessed the level of interaction with Staufen1-VC.
We did not detect fluorescence complementation in the
cells (M.P.M. & A.J.M., data not shown).
When we tethered MS2-VN and MS2-Staufen1 to the
mRNA via MS2BS and expressed Gag-VC, TriFC was
readily detected, indicating that Staufen1, when bound to
mRNA, recruits Gag (Figure 8D). These results demon-
strate that Gag potentially recruits cellular factors while
bound to an mRNA; and likewise, RNA-binding host fac-
tors can recruit Gag to mRNA. The results also support
the notion that the HIV-1 RNP, containing at its core the
precursor Gag and the genomic RNA, will selectively
engage cellular factors such as Staufen1 and IMP1 during
assembly.
Discussion
Gag-Staufen1 interactions in living cells
Staufen1 was previously found as a component of HIV-1
particles [24,55]. We have uncovered additional roles for
this host factor including one in promoting Gag multi-
merization and assembly and another in the selection of
vRNA for encapsidation [24,49]. In the present study, we
extend our understanding of Staufen1's role in HIV-1
replication by characterizing its interactions with Gag
using two powerful, live cell fluorescence complementa-
tion techniques. We demonstrate that Staufen1 interacts
with Gag, that Staufen1 recruits Gag when it is bound to
mRNA and likewise, Gag recruits Staufen1 when bound
to the cognate psi packaging signal. The results highlight
Staufen1's involvement in the HIV-1 RNP in the assembly
of HIV-1.
Recruitment of Staufen1 by Gag to lipid rafts and to mRNA
Our earlier work demonstrated that when we modulated
Staufen1 levels in cells, Gag-Gag interactions increased,
and these accumulated in detergent-resistant complexes
[21]. Here, we used BiFC to evaluate where Staufen1 and
Gag interact. This approach, which employs native GagFigure 7 TriFC analysis for studying RNA-protein interactions in live cells. (A) Depiction of the TriFC analysis employed in the study. The mRNA-
reporter molecule contains HIV-1 vRNA packaging signal psi in close proximity to the integrated MS2 RNA-binding site (MS2BS). MS2-VN binds MS2BS 
to tether to the mRNA molecule. The C-terminal moiety of Venus (VC) is expressed as hGag-VC fusion and binding of hGag-VC to the RNA packaging 
sequence (psi domain) will bring both VN and VC Venus moieties in close enough proximity to generate a fluorescent signal by VN-VC complemen-
tation. (B) A 19-basepair deletion from SL3 of psi prevents the binding between hGag-VC and psi RNA and does not yield fluorescence complemen-
tation. (C) HeLa cells were grown on coverslips and transfected with pGL3MS2site-psi, MS2-VN and Gag-VN. 24 hr later laser scanning confocal 
microscopy was used to assess TriFC. Bright fluorescence signals in cytoplasmic punctae were detected indicating that the interaction between hGag-
VC and the psi RNA domain occurred. This condition represented a positive control for the TriFC system employed here. TriFC signals were not detect-
ed when HeLa cells were transfected with the mutated psi reporter (pGL3MS2site-Delta-psi) (D). In order to determine the specificity of the TriFC assay, 
HeLa cells were co-transfected with plasmids expressing either Staufen1-VC (E) or IMP1-VC (F) along with MS2-VN and pGL3MS2site-psi. TriFC was 
absent in all cells examined indicating that Staufen1 and IMP1 do not bind the psi RNA. In parallel experiments, Gag did not associate with mRNA 
reporter bearing β-Actin zipcode sequence (pGL3-βActin zipcode) (G) whereas IMP1 did (H), as expected [33]. Phase contrast images are shown on 
the left of each panel in (C)-(H). The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
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sequences, has become increasingly popular to visualize
Gag in cells [56]. While Staufen1 and Gag are shown to
associate in cytoplasmic compartments, our results also
reveal that these interactions occur on membranes and at
the plasma membrane where Gag multimerizes during
assembly [6,21]. Whereas Staufen1 is usually found to
localize on reticulotubular structures and the endoplas-
mic reticulum [26], we show that Staufen1 is recruited
from the cytoplasm to lipid rafts at the plasma membrane
where it interacts with Gag. Consistently, Staufen1 co-
localizes with Gag and vRNA at this location [49], and the
distribution of the Staufen1-interacting partner, UPF1,
also shuttles to the plasma membrane domain in HIV-1
expressing cells [32]. Here, Gag expression alone appears
to be the driving force behind Staufen1 recruitment to
GM1-positive plasma membrane domains that serve as
the main platforms for viral assembly [57]. Gag's ability to
recruit host factors and bind psi RNA concomitantly, via
the same protein domain (NC), reveals a rather multifac-
eted property of Gag and further strengthens the implica-
tion of Staufen1 in HIV-1 assembly [21]. Furthermore,
time-lapse confocal imaging showed that Gag-Staufen1
foci are mobile and dynamic and are able to merge with
similar structures and separate over time into smaller
particles that traffic to and anchor at the plasma mem-
brane (Additional file 2: Figure S2). Consistently, distinct
populations of Gag and Staufen1 (and the vRNA) traffic
on endosomal membranes in cells [13,14]. Moreover, the
Gag-vRNA interactions as well intermediary Gag assem-
bly domains have been found in juxtanuclear domains
[15,58-60]. Thus, we propose that Staufen1 is hijacked by
Gag shortly after its synthesis in order to assist in traffick-
ing and assembly.
There are potentially two caveats with respect to the
TriFc method used here. First is the use of codon-opti-
mized hGag, that when expressed, could result in devia-
tions in transport and assembly. Nevertheless, several
recent studies have utilized Rev-independent hGag
expressors to uncover new information on intracellular
Gag trafficking and Gag interacting partners [6,29,56].
Furthermore, we show that by employing a Rev-depen-
dent Gag expressor in a modified TriFC analyses nearly
identical TriFC signals were obtained, revealing that
codon-optimization of hGag did not have a significant
bearing on the results. The second caveat is the possibil-
ity for an alternative interpretation that includes the
order in which the protein-protein and protein-RNA
interactions occur. We are claiming that either Gag or
Staufen1 recruits the other partner while bound to
mRNA, and this is supported by BiFC and endogenous
Figure 8 Gag recruits host proteins Staufen1 and IMP1 while tethered to mRNA. HeLa cells were co-transfected with mRNA-reporter pGL3-ba-
sic/site, MS2-VN, MS2-Gag or MS2-Staufen1 and hGag-VC, Staufen1-VC or IMP-VC as indicated. TriFC analysis was performed at 24 and 40 hr post-trans-
fection. MS2 RNA-tethered hGag recruits Gag (A), Staufen1 (B) and IMP1 (C) to generate TriFC signals in cells. MS2 RNA-tethered Staufen1 recruits 
hGag (D). Western blotting analysis for Staufen1, p24 (to identify Gag), and GFP (that recognizes C terminal part of Venus) and Luciferase (reporter 
mRNA, pGL3-basic/site expressed Luciferase) confirmed expression of DNA constructs. Negative controls included transfections that omitted either 
the VC fusion proteins (bottom left in panels (A)-(D)) or the bridging MS2 molecule (MS2-hGag, MS2-Gag(C36S) or MS2-Staufen1; data not shown). 
The size bars are equal to 10 μm.Milev et al. Retrovirology 2010, 7:41
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Staufen1 staining (Figure 2). However, the bimolecular
interaction between Gag and Gag and that found
between Staufen1 and Gag could represent the initial
event after which the bimolecular complex co-traffics to
the mRNA substrate. Even though the KD  for MS2-
MS2BS interaction is in the low nanomolar range, further
work will be necessary in order to confidently differenti-
ate between some of these possibilities.
Involvement of Staufen1 in the anterograde trafficking of 
Gag
We recently showed that a population of Staufen1 associ-
ates along with Gag and vRNA on endosomal membranes
[13]. Likewise, RNPs translocate within cells by making
use of machineries that direct traffic of cellular mem-
branes and vesicles (reviewed in [61]). In this study we
wanted to characterize the possible roles of Staufen1 in
the transport and distribution of multimerizing Gag-Gag
that we can readily visualize in live cells. To resolve this,
we modulated Staufen1 expression levels in cells that
expressed Gag-VN/Gag-VC. When we depleted
Staufen1, Gag-Gag BiFC signals were found at the plasma
membrane but also in the cytoplasm at juxtanuclear
regions on what appeared to be endosomal membrane
vesicles. We suspect that the Gag-Gag BiFC signals are
due to coalescing HIV-1 RNPs that tether to endosomal
membrane populations that may not traffic properly.
These were identified in earlier work [13] and were found
to form in an HIV-1-dependent manner containing
Staufen1, Gag (and Gag multimers) and vRNA reactivity
later named Staufen1 HIV-1-dependent ribonucleopro-
teins (SHRNPs; [49]). The data shown here are consistent
with the enhanced Gag-Gag multimerization in Staufen1-
depleted cells that we found using another biophysical
technique (bioluminescence resonance energy transfer)
[21], but also reveal some of the principal locations of
these events (at juxtanuclear and raft domains) [22,49]. It
is possible that, during viral egress, Gag mediates the for-
mation of its own mixed type of membranes bearing sev-
eral endosomal marker proteins similar to those that
other viruses engineer [62]. Of interest are data from
recently published work in which the accumulation of
HIV-1 Gag and cholesterol-enriched membranes was
observed in juxtanuclear late endosomal compartments
in Niemann-Pick type C1-deficient cells [63]. Further-
more, the targeted depletion of the suppressor of
cytokine signalling 1 reduced the transport of Gag to the
plasma membrane, leading to accumulations of it near
the nucleus [64]. In addition, strong co-localization
between another late endosomal marker, CD63, and Gag
was observed as a result of Rab9 depletion [65]. These
domains appear to be important for steps in assembly
including Gag-Gag and Gag-vRNA associations
[13,58,59], vRNA encapsidation [49] and Gag trafficking
[60,66] and in one case, for Gag degradation [64]. Impor-
tantly, we showed that the cytoplasmic accumulations of
Gag did not form because of endocytosed Gag or viral
particles derived from the plasma membrane (Additional
file 4: Figure S4). These results suggest that the Staufen1
plays roles in the anterograde transport of Gag, but is also
a host factor involved in the formation of the HIV-1 RNP
during viral egress and assembly.
Conclusions
In the present study, we demonstrate that the intermolec-
ular associations between the host mRNA-binding pro-
tein Staufen1 and HIV-1 Gag occur in the cytoplasm and
at the plasma membrane in HeLa cells and T lympho-
cytes. Furthermore, we demonstrate that Staufen1 is
recruited by Gag to lipid raft microdomains and present
results that indicate Staufen1 has potentially novel func-
tions in the intracellular trafficking of HIV-1 Gag during
viral egress.
Methods
Cell culture and transfections
HeLa cells and Jurkat T cells were maintained under stan-
dard conditions at 37°C with in Dulbecco's modified
Eagle's medium or RPMI, respectively, supplemented
with 10% fetal bovine serum (FBS), 100 units/ml penicil-
lin and 100 mg/ml streptomycin (Invitrogen). Lipo-
fectamine 2000 (Invitrogen) was used for the DNA
transfections of Jurkat T cells or HeLa cells according to
the manufacturer's protocol. 1 day before transfection
1.5-1.8 × 105 or 4-5 × 105 HeLa cells were seeded in 6-well
plates or 60-mm dishes, respectively to have ~60% con-
fluency when transfected. 106 Jurkat T cells were trans-
fected in 25 ml tissue culture flasks.
BiFC and TriFC analysis
For the BiFC and TriFC experiments, HeLa cells were
plated on poly-D-lysine-coated 18 mm micro-glass cover-
slips (VWR) or 40 mm Bioptechs cover glasses 20-24 hr
prior to transfection. Cells were transfected with 1.5 μg to
3 μg plasmid DNA per 18 mm and 3 μg to 5 μg per 40 mm
depending on the design of the experiment. Jurkat T cells
were transfected in suspension. At 24 hr post-transfec-
tion coverslips (HeLa cells) were mounted on a Bioptechs
FCS3 imaging perfusion chamber (Bioptechs, Inc.), con-
tinuously perfused with fresh medium and warmed using
a heating element (Bioptechs, Inc.). For Jurkat T cells, cell
adherence to coverslips was promoted using poly-D-
lysine (Sigma-Aldrich, Inc). Live cell imaging was per-
formed at 37°C using either Zeiss Pascal LSM5 confocal
microscope (Carl-Zeiss, Inc.) with 63×1.3 oil immersion
objective or inverted Leica fluorescence microscope.
Time-lapse images were captured using 63×1.3 oil
immersion objective mounted on a motorized LeicaMilev et al. Retrovirology 2010, 7:41
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microscope equipped with a PerkinElmer ERS spinning
disk confocal system with heated stage and chamber to
maintain the cells at 37°C and CO2. Images were collected
at the times shown or as stated otherwise, for the indi-
cated period. Two-dimensional data sets were deconvo-
luted using AutoDeblur (MediaCybernetics, Inc.) and
compiled using Imaris 6.3.1 software (Bitplane, Inc.). In
some experiments, BiFC and TriFC signals were mea-
sured in two-dimensional single confocal planes using
Imaris software.
Immunofluorescence and Fluorescence in situ 
hybridization (IF/FISH) analyses
Laser scanning confocal microscopy was performed
using a Leica microscope equipped with a PerkinElmer
ERS spinning disk or a Carl-Zeiss LSM5 Pascal confocal
microscope . Combined 2- and 3-colour IF/FISH co-anal-
yses were performed exactly as described [13]. Images
were captured at 512×512 or at 1024×1024 pixels resolu-
tion.
SDS-PAGE, Western blot analysis and antibodies
SDS-PAGE and western blotting were performed as
described earlier [49]. Antibodies used included: rabbit
anti-Caveolin-1 (Santa Cruz); rabbit anti-Tuberin (TSC1,
Abcam); rabbit anti-p24 (Intracell); mouse anti-p24
(NIH); rabbit anti-IMP1 (gift from Finn Nielsen, Rigshos-
pitalet, Copenhagen, Denmark); mouse or rabbit anti-
Staufen1 (gifts from Luc DesGroseillers, Université de
Montréal, Canada and Graciela Boccaccio, University
LeLoir, Argentina); rabbit anti-ABCE1 (a gift from Jais
Lingappa, University of Washington); mouse anti-GFP
(Roche) and mouse anti-Luciferase (Sigma-Aldrich).
Lipid rafts staining
To visualize the distribution of insoluble membrane
microdomains we used Vybrant Lipid Raft Labeling Kit
(Invitrogen) according to the manufacturer's protocol.
The method relies on the binding of a red-fluorescent
AlexaFluor 594 conjugate of cholera toxin subunit B (CT-
B) to the pentasaccharide chain of plasma membrane
ganglioside GM1 (a lipid raft marker). An antibody that
r e c o g n i z e s  C T - B  i s  t h e n  u s e d  t o  c r o s s - l i n k  t h e  C T - B -
labeled lipid rafts into distinct patches on the plasma
membrane, which we visualized by microscopy. The cov-
erslips with stained live cells were mounted on Bioptechs
FCS3 live cell perfusion chamber and were visualized by
laser scanning confocal microscopy.
Isolation and analysis of detergent-free lipid rafts
We used a simplified method for the fractionation of lipid
rafts that does not require the use of detergent [45]. All
procedures were carried out with RNAse-free equipment
and materials and on ice. Briefly, for each of the cases,
two 175 cm2 of HeLa cells were transfected with corre-
sponding plasmids. 24 hr later they were washed 3 times
and scraped into buffer B1 (20 mM Tris-HCl pH7.8, 250
mM sucrose, 1 mM CaCl2, 1 mM MgCl2 and RNAse out
(Invitrogen) 1 μl/5 ml), centrifuged for 5 min at 1500 rpm
and resuspended again in 1 ml of buffer B1 containing
complete protease inhibitor cocktail (Roche). The cells
were homogenized in RNAse free 1.5 ml Eppendorf tubes
with plastic pestles, centrifuged at 1000 rpm for 10 min
and the supernatant (S1) was collected. The pellet was
lysed in 1 ml of B1 and homogenized again. Following
centrifugation at 500 × g for 10 min, the second superna-
tant (S2) was collected and mixed with S1 (total ~2 ml). 2
ml of 50% OptiPrep (diluted in B1 without Ca2+ and Mg2+
to reach 50%) was added to S1 and S2. The resulting 4 ml
of 25% OptiPrep mixture was first poured in 12 ml cen-
trifugation tubes (Beckman Coulter). A step gradient 0-
20% was then created using 1.6 ml of 20%, 15%, 10%, 5%
and 0% OptiPrep mixtures. The samples were centrifuged
in a Beckman ultracentrifuge for 90 min at 52 000 × g
with rotor SW41. After centrifugation 0.66 ml fractions
(18 in total) starting from the top of the tube were col-
lected and 150 μl were used for western blot analysis.
Optical densities of resultant bands were quantified using
ImageJ software (freeware from the NIH) as described
[59].
Cholesterol depletion
For the complete depletion of cellular cholesterol in live
cells, cells were first stained with Vybrant Lipid Raft
Labeling Kit (Invitrogen). Coverslips were then mounted
in Bioptechs environmental chamber and by perfusion
DMEM medium was exchanged with DMEM containing
30 mM 2-hydroxypropyl-β-cyclodextrin (HβCD) [67].
Pictures were taken at t = 0 min before addition HβCD
and at different time points after addition as indicated in
the figures.
Plasmid expression constructs and siRNAs
The plasmids pMS2-Venus, pMS2-VN, pStaufen1-VC,
pIMP1-VC, pFMRP-VC, pGL3-basic/site and pGL3-
βActin zipcode have been described previously [33]. To
generate pMS2-Staufen1, pMS2-humanized(h)Gag and
pMS2-Gag(C36S) vectors Staufen1, hGag and Gag(C36S)
sequences were amplified by PCR from pcDNA-
Staufen1-TAP [68], pCMV55M1-10 [24] and
pNL4.3(C36S) [69] and replaced the VN sequence from
pMS2-VN between XhoI and NotI. To generate phGag-
VenusC and pGag(C36S)-VenusC, hGag and Gag(C36S)
(amplified from pNL4.3(C36S) [69]) PCR fragments
replaced IMP1 sequence from pIMP1-VenusC between
NheI and XhoI. The Rev-responsive Gag expressor, pSV-
GagRRE-R was generously supplied by David Rekosh
(University of Virginia, U.S.A.; [70]).Milev et al. Retrovirology 2010, 7:41
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For the generation of mRNA reporter expressing plas-
mids pGL3MS2site-psi  or pGL3MS2site-Delta-psi  the
fragments containing vRNA packaging signal psi (52 bp)
and delta psi  (33 bp) were amplified from plasmids
HxBRU and plasmid pHXBAP1 [24] and cloned in
pGL3MS2site/basic vector between NheI and XhoI. All
plasmids were purified using the Sigma GeneElute Maxi-
prep kit. pCMV-Rev was obtained from the National
Institutes of Health AIDS Research and Reference
Reagent Program. The complete list of plasmids used in
this work is given in Table 1.
siRNAs used to deplete Staufen1 (targeting both iso-
forms - 55 and 63 kDa, siStaufen) or the higher molecular
weight isoform (Staufen1-63 kDa) were described earlier
[22,49].
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